Observe Medical Asa Cash Flow Conversion Efficiency
Observe Medical Asa cash flow conversion efficiency. Based on the latest financial reports, Observe Medical Asa (OBSRV) has a cash flow conversion efficiency ratio of -0.829x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-24.83 Million ≈ $-2.61 Million USD) by net assets (Nkr29.96 Million ≈ $3.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Observe Medical Asa (2016–2025)
Cash flow conversion efficiency of Observe Medical Asa from 2016 to 2025. This chart illustrates how Observe Medical Asa's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Observe Medical Asa for real-time trading data and today's change.
Observe Medical Asa Cash Flow Conversion Ratio Explained
Observe Medical Asa cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Observe Medical Asa Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Observe Medical Asa ranked by their cash flow conversion efficiency. Also see OBSRV market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rayong Wire Industries Public Company Limited
BK:RWI
|
-0.006x |
|
Mida Leasing Public Company Limited
BK:ML
|
0.018x |
|
Ganges Securities Limited
NSE:GANGESSECU
|
0.035x |
|
Vo2 Cap Holding AB
ST:VO2
|
0.045x |
|
Prg Holdings Bhd
KLSE:7168
|
-0.011x |
|
Prochem S.A.
WAR:PRM
|
0.055x |
|
BALAXI PHARMACEUTICALS LIMITED
NSE:BALAXI
|
0.060x |
|
GreenPro Capital Corp
NASDAQ:GRNQ
|
-0.061x |
Annual Cash Flow Conversion Efficiency for Observe Medical Asa (2016–2025)
The table below shows the annual cash flow conversion efficiency of Observe Medical Asa from 2016 to 2025. Review OBSRV financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr29.96 Million ≈ $3.15 Million |
Nkr-24.83 Million ≈ $-2.61 Million |
-0.829x | +34.86% |
| 2024-12-31 | Nkr24.11 Million ≈ $2.54 Million |
Nkr-30.68 Million ≈ $-3.23 Million |
-1.273x | -483.24% |
| 2023-12-31 | Nkr112.08 Million ≈ $11.79 Million |
Nkr-24.45 Million ≈ $-2.57 Million |
-0.218x | +41.25% |
| 2022-12-31 | Nkr138.31 Million ≈ $14.55 Million |
Nkr-51.37 Million ≈ $-5.41 Million |
-0.371x | -123.71% |
| 2021-12-31 | Nkr-14.12 Million ≈ $-1.49 Million |
Nkr-22.13 Million ≈ $-2.33 Million |
1.567x | +247.31% |
| 2020-12-31 | Nkr20.35 Million ≈ $2.14 Million |
Nkr-21.64 Million ≈ $-2.28 Million |
-1.064x | -10.69% |
| 2019-12-31 | Nkr14.54 Million ≈ $1.53 Million |
Nkr-13.97 Million ≈ $-1.47 Million |
-0.961x | -93.26% |
| 2018-12-31 | Nkr16.82 Million ≈ $1.77 Million |
Nkr-8.36 Million ≈ $-880.11K |
-0.497x | +42.36% |
| 2017-12-31 | Nkr11.39 Million ≈ $1.20 Million |
Nkr-9.83 Million ≈ $-1.03 Million |
-0.863x | -21.31% |
| 2016-12-31 | Nkr14.70 Million ≈ $1.55 Million |
Nkr-10.45 Million ≈ $-1.10 Million |
-0.711x | -- |
About Observe Medical Asa
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a dig… Read more